Manoj Raghavan

Employment

• University Hospitals Birmingham NHS Foundation Trust Consultant Haematologist
  2010 - Present
• University of Birmingham Honorary Associate Professor
  2010 - Present
• Barts and The London School of Medicine and Dentistry Clinical Senior Lecturer
  2007 - 2010
• Barts and The London School of Medicine and Dentistry Clinical Research Fellow
  2003 - 2007
• University College London Hospitals NHS Foundation Trust Specialist Registrar
  1998 - 2003

Education

• Barts and The London School of Medicine and Dentistry PhD
  2003 - 2008
• Royal College of Pathologists FRCPath
  2001 - 2002
• Royal College of Physicians MRCP (UK)
  1996 - 1998
• St. George's, University of London MBBS
  1991 - 1994
• University of Cambridge BA Hons
  1988 - 1991

Projects & Funding

Projects & funding information is unavailable.

Publications (48)

• Navigating through uncertainty—Experience from the <scp>UK</scp> national <scp>VEXAS MDT</scp>
  British Journal of Haematology 2026 1 citation DOI: 10.1111/bjh.70365
  +Save
• Introduction of whole genome sequencing as NHS standard of care for glioma patients in two neurosurgical oncology centres: West Midlands
  BJC Reports 2025 0 citations DOI: 10.1038/s44276-025-00168-9
  +Save
• An evaluation of a real-world, multi-disciplinary, treatment-free remission programme for patients with Chronic Myeloid Leukaemia
  Journal of Oncology Pharmacy Practice 2025 0 citations DOI: 10.1177/10781552251384611
  +Save
• A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression
  Nature Communications 2025 6 citations DOI: 10.1038/s41467-025-60192-8
  +Save
• The genomic analysis of patients with musculoskeletal metastases from an unknown origin
  Surgical Oncology 2025 0 citations DOI: 10.1016/j.suronc.2025.102187
  +Save
• The potential clinical utility of Whole Genome Sequencing for patients with cancer: evaluation of a regional implementation of the 100,000 Genomes Project
  British Journal of Cancer 2024 12 citations DOI: 10.1038/s41416-024-02890-6
  +Save
• Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
  Leukemia 2024 12 citations DOI: 10.1038/s41375-024-02411-7
  +Save
• The evolving genetic landscape of telomere biology disorder dyskeratosis congenita
  EMBO Molecular Medicine 2024 29 citations DOI: 10.1038/s44321-024-00118-x
  +Save
• Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
  iScience 2024 10 citations DOI: 10.1016/j.isci.2024.109576
  +Save
• Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth.
  Nature communications 2024 34 citations DOI: 10.1038/s41467-024-45691-4
  +Save